SS Innovations International Inc. (NASDAQ: SSII) has appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026, as the company accelerates its global expansion and regulatory initiatives for its SSi Mantra surgical robotic system.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. She previously served as CFO at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn and strengthen the company’s balance sheet.
The appointment comes at a pivotal time for SS Innovations, which is pursuing broader commercialization of its SSi Mantra robotic surgical platform while continuing preparations for U.S. Food and Drug Administration review (https://nnw.fm/yY4UM). The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries. This underscores SS Innovations’ emphasis on surgeon education alongside technology deployment.
The addition of Romano is expected to bolster the company’s financial strategy as it navigates the capital-intensive process of gaining FDA clearance and expanding internationally. Her experience in capital markets and public-company finance could prove crucial as SS Innovations seeks to fund its growth initiatives and manage operational costs.
SS Innovations has been making strides in the global robotic surgery market, which is projected to grow significantly in the coming years. The SSi Mantra system is designed to offer a cost-effective alternative to existing robotic surgical platforms, potentially expanding access to minimally invasive surgery in emerging markets.
The company’s focus on training is evident from the SSICRS program, which aims to build a pipeline of skilled surgeons capable of using the SSi Mantra system. By training healthcare professionals from multiple countries, SS Innovations is laying the groundwork for international adoption of its technology.
Investors and industry observers will be watching closely as the company progresses toward FDA submission and continues to expand its global footprint. The appointment of a seasoned CFO like Romano signals a commitment to financial discipline and strategic growth.
For more information on SS Innovations and its latest developments, visit the company’s newsroom at https://nnw.fm/SSII.
